|
[1]
|
Singer, M., Deutschman, C.S., Seymour, C.W., Shankar-Hari, M., Annane, D., Bauer, M., et al. (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315, 801-810. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Gavelli, F., Castello, L.M. and Avanzi, G.C. (2021) Management of Sepsis and Septic Shock in the Emergency Department. Internal and Emergency Medicine, 16, 1649-1661. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Rudd, K.E., Johnson, S.C., Agesa, K.M., Shackelford, K.A., Tsoi, D., Kievlan, D.R., et al. (2020) Global, Regional, and National Sepsis Incidence and Mortality, 1990-2017: Analysis for the Global Burden of Disease Study. The Lancet, 395, 200-211. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Seymour, C.W., Kennedy, J.N., Wang, S., Chang, C.H., Elliott, C.F., Xu, Z., et al. (2019) Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA, 321, 2003-2017. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Gyawali, B., Ramakrishna, K. and Dhamoon, A.S. (2019) Sepsis: The Evolution in Definition, Pathophysiology, and Management. SAGE Open Medicine, 7. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Arina, P. and Singer, M. (2021) Pathophysiology of Sepsis. Current Opinion in Anaesthesiology, 34, 77-84. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
刘柱, 王佳巍, 严静, 等. 中医药调控PI3K/Akt通路干预脓毒症的研究进展[J]. 中国实验方剂学杂志, 2025, 31(2): 314-322.
|
|
[8]
|
薛燕红, 杨秀芬. 脓毒症急性肺损伤的发病机制及治疗进展[J]. 河北医科大学学报, 2024, 45(4): 406-412.
|
|
[9]
|
Clements, T.W., Tolonen, M., Ball, C.G. and Kirkpatrick, A.W. (2021) Secondary Peritonitis and Intra-Abdominal Sepsis: An Increasingly Global Disease in Search of Better Systemic Therapies. Scandinavian Journal of Surgery, 110, 139-149. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Hu, P., Yuan, M., Guo, B., Lin, J., Yan, S., Huang, H., et al. (2024) Citric Acid Promotes Immune Function by Modulating the Intestinal Barrier. International Journal of Molecular Sciences, 25, Article No. 1239. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Liu, Z., Zhang, Z., Chen, X., Ma, P., Peng, Y. and Li, X. (2023) Citrate and Hydroxycinnamate Derivatives from Mume Fructus Protect LPS-Injured Intestinal Epithelial Cells by Regulating the FAK/PI3K/AKT Signaling Pathway. Journal of Ethnopharmacology, 301, Article ID: 115834. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Du, M., Liu, X., Ji, X., Wang, Y., Liu, X., Zhao, C., et al. (2025) Berberine Alleviates Enterotoxigenic Escherichia coli-Induced Intestinal Mucosal Barrier Function Damage in a Piglet Model by Modulation of the Intestinal Microbiome. Frontiers in Nutrition, 11, Article ID: 1494348. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Duda-Madej, A., Gagat, P., Wiśniewski, J., Viscardi, S. and Krzyżek, P. (2025) Impact of Isoquinoline Alkaloids on the Intestinal Barrier in a Colonic Model of Campylobacter Jejuni Infection. International Journal of Molecular Sciences, 26, Article No. 10634. [Google Scholar] [CrossRef]
|
|
[14]
|
吴华顺, 彭嘉雯, 孙巧茹. 减味涤痰定痫汤联合利培酮治疗精神分裂症的临床观察[J]. 中国民间疗法, 2022, 30(11): 61-63.
|
|
[15]
|
诸婧, 张金华, 盛平卫, 等. 龙胆泻肝汤减味治疗急性期湿疹临床研究[J]. 中国实用医药, 2019, 14(27): 8-10.
|